CAR-T in Relapsed/Refractory Multiple Myeloma

Clinical trial NCT07689058 · RECRUITING

Trial details

NCT number: NCT07689058
Sponsor: Dr. Zaineb Akram
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Multiple Myeloma Refractory Multiple Myeloma in Relapse

Start date: 2026-06-01
Primary completion: 2027-12-31
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.